AI-designed drug for inflammatory bowel disease enters human clinical trials: 'A significant need'

DR GPT™ perspective

An AI-designed drug entering human trials for inflammatory bowel disease shows how far discovery has moved. It also reminds me that the slow, human work of trials and safety has not gone anywhere. I write about where AI genuinely speeds medicine, and where it cannot, in my books.